The company
NeuroOne Medical Technologies Corporation
NMTC · Nasdaq
NMTC stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 37 weeks. It is 66.0% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 37
- Industry in uptrend
- 29% -5 in 4 wk
- Insider buys, 12 months
- $1.5M
- Insider sales, 12 months
- $110K
- Officials’ trades on record
- 0
- Institutions holding
- 26 (-5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David J. WambekeChief Business Officer | bought | 33,333at $2.01 | 27 Aug 2026filed 8 Sep 2026 |
| Mark ChristiansonMarket Development Director | sold | 10,000at $3.18 | 30 Jun 2026filed 2 Jul 2026 |
| Mark ChristiansonBusiness Development Director | sold | 15,363at $0.74 | 30 Mar 2026filed 1 Apr 2026 |
| Mark ChristiansonBusiness Development Director | sold | 100at $0.80 | 13 Mar 2026filed 16 Mar 2026 |
| Mark ChristiansonBusiness Development Director | sold | 817at $0.80 | 12 Mar 2026filed 16 Mar 2026 |
| Mark ChristiansonBusiness Development Director | sold | 2,109at $0.80 | 11 Mar 2026filed 12 Mar 2026 |
| Mark ChristiansonBusiness Development Director | sold | 11,611at $0.80 | 10 Mar 2026filed 12 Mar 2026 |
| David J. WambekeChief Business Officer | bought | 1,000,000at $0.6704 | 1 Mar 2026filed 3 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Bleichroeder LPreduced · filed 13 Aug 2026 | 666,666$2.0M | -3,333,334−83.3% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 352,774$1.1M | -1,044,555−74.8% |
| BARD ASSOCIATES INCreduced · filed 12 Aug 2026 | 305,428$929K | -1,535,070−83.4% |
| PERKINS CAPITAL MANAGEMENT INCreduced · filed 24 Jul 2026 | 244,656$744K | -1,228,344−83.4% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 93,555$284K | -522,051−84.8% |
| Sio Capital Management, LLCreduced · filed 14 Aug 2026 | 82,767$252K | -413,847−83.3% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 70,861$215K | -584,585−89.2% |
| VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026 | 49,018$149K | -243,063−83.2% |
| ESSEX INVESTMENT MANAGEMENT CO LLCreduced · filed 6 Aug 2026 | 43,578$132K | -218,375−83.4% |
| BlackRock, Inc.new · filed 7 Aug 2026 | 25,121$76K | +25,121 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.